Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-23-048554

Director sold 2,000 shares at $1.03 ($2,060)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Henderson Jeffrey William · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-09-01 Sale : show line 1 in the form 10b5-1 −2,000 $1.03 $2,060 28,866 D
Open-market sales · 2,000 sh · avg $1.03 · $2,060
Loading xslF345X05/doc4.xml…